Israel's Teva To Buy Cephalon Of U.S. For $6.2 billion
This article was originally published in PharmAsia News
Executive Summary
Teva Pharmaceutical Industries of Israel apparently outbid Canada's Valeant Pharmaceuticals International to buy Cephalon